Showing results (651-660 of 669) with videos related to

Sort By:
Pageof 67
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 1Giuseppe Giaccone, Roy S Herbst, Christian Manegold, et al.
Physiological Measurement|June 4, 2009
GREIT: a unified approach to 2D linear EIT reconstruction of lung imagesAndy Adler, John H Arnold, Richard Bayford, et al.
Cancer Immunology, Immunotherapy : CII|September 20, 2011
A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patientsOsama E Rahma, Ed Ashtar, Malgorzata Czystowska, et al.
Cell|January 14, 2004
Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotesPek Yee Lum, Christopher D Armour, Sergey B Stepaniants, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 7, 2018
A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women over age 50 with BI-RADS 3, 4, or 5 AssessmentMeredith C Henderson, Michael Silver, Quynh Tran, et al.
Kidney International|December 26, 2021
Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) studyLihong Bu, Gaurav Gupta, Akshta Pai, et al.
Seminars in Thrombosis and Hemostasis|November 25, 2000
Molecular biology and clinical manifestation of hereditary factor VII deficiencyF H Herrmann, K Wulff, K Auberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancerJanos L Tanyi, Yutaka Hasegawa, Ruth Lapushin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 30, 2007
Role of CYP3A and CYP2E1 in alcohol-mediated increases in acetaminophen hepatotoxicity: comparison of wild-type and Cyp2e1(-/-) miceKristina K Wolf, Sheryl G Wood, Jenna L Allard, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 6, 2005
Role of the nuclear receptor pregnane X receptor in acetaminophen hepatotoxicityKristina K Wolf, Sheryl G Wood, Jane A Hunt, et al.
Pageof 67